Pasi Koskimies

USPTO Granted Patents = 15 (Patent Applications = 5)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

Solvay Pharmaceuticals, B.v.

patents

4. 2 out of 75

Solvay Pharmaceuticals, Gmbh

patents

where one patent can have more than one assignee

Years Active: 2008-2022

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11254703 - Therapeutically active steroidal derivatives (2022-02-22),

2. 10717761 - Therapeutically active steroidal derivatives (2020-07-21),

3. 10626140 - Prodrugs of 17β-HSD1-inhibitors (2020-04-21),

4. 10413557 - Prodrugs of 17.BETA.-HSD1-inhibitors (2019-09-17),

5. 10377791 - Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1 (2019-08-13),

6. 9850272 - Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1 (2017-12-26),

7. 9663549 - Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase (2017-05-30),

8. 8435973 - 17-beta HSD1 and STS inhibitors (2013-05-07),

9. 8288367 - Substituted estratriene derivatives as 17BETA HSD inhibitors (2012-10-16),

10. 8088758 - 17β-hydroxysteroid dehydrogenase type I inhibitors (2012-01-03),

11. 8080540 - Therapeutically active triazoles and their use (2011-12-20),

12. 8030298 - 17β-HSD1 and STS inhibitors (2011-10-04),

13. 7754709 - Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds (2010-07-13),

14. 7524853 - Compounds and their use in therapy (2009-04-28),

15. 7465739 - Compounds and their use in therapy (2008-12-16),

Title: Innovations of Pasi Koskimies in Therapeutic Development

Introduction

Pasi Koskimies, an innovative inventor based in Turku, Finland, boasts an impressive portfolio of 15 patents. His work primarily focuses on the development of therapeutically active compounds, showcasing his dedication to advancing medical science.

Latest Patents

Koskimies' latest patents revolve around therapeutically active steroidal derivatives. The inventions detail compounds characterized by specific formulas, particularly in their role as inhibitors of the enzyme 17β-HSD1. These compounds are designed for the treatment or prevention of steroid hormone-dependent diseases or disorders. They hold promise for conditions necessitating the inhibition of the 17β-HSD1 enzyme and lowering endogenous estradiol concentrations. Each patent also encompasses the preparation of these compounds and various pharmaceutical compositions containing them as active ingredients.

Career Highlights

Throughout his career, Pasi Koskimies has contributed significantly to pharmaceutical advancements while working with reputable companies such as Forendo Pharma Ltd and Abbott Products GmbH. His expertise has positioned him as a valued innovator in the research and development of therapeutic solutions.

Collaborations

Pasi collaborates with noteworthy colleagues in the field, including Leena Hirvelä and Josef Messinger. These partnerships underscore the collaborative spirit present in the pursuit of medical innovation, further enhancing the potential impact of their collective research.

Conclusion

With 15 patents to his name, Pasi Koskimies continues to make significant strides in the field of pharmaceuticals. His groundbreaking work on steroidal derivatives illustrates the critical role of inventors in developing innovative solutions that can transform healthcare and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.